Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer
High PIV values are associated with worse clinical outcomes, reinforcing its role as a reliable prognostic biomarker in advanced-stage PC. These findings underscore the importance of PIV in guiding therapeutic strategies and warrant further investigation in larger cohorts.
Authors
- Mustafa Yıldız (ORCID: https://orcid.org/0000-0001-7832-5989)
- Rıdvan Yavuz (ORCID: https://orcid.org/0000-0002-9528-2148)
- Halil Goksel Guzel
- Arif Hakan Önder (ORCID: https://orcid.org/0000-0002-0121-5228)
- Erkan Kayıkçıoğlu (ORCID: https://orcid.org/0000-0002-7401-5446)
- Ahmet Ünlü (ORCID: https://orcid.org/0000-0001-6654-3815)
- Mehmet Acun (ORCID: https://orcid.org/0000-0003-1649-348X)
- Halit Özgül (ORCID: https://orcid.org/0009-0006-6457-9738)
- Banu Öztürk (ORCID: https://orcid.org/0000-0003-0290-8787)
- Asım Armağan Aydın
Institutions
- Antalya Bilim University (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Istinye University (TR)
- Antalya IVF (TR)
Publication Details
- Journal
- Cureus
- Published
- 2024-10-11
- DOI
- https://doi.org/10.7759/cureus.71251
- Citations
- 6
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.70